GWPH


6 Positive Catalysts to Drive GW Pharmaceuticals (GWPH) Stock Further

The good news for GW Pharmaceuticals (GWPH) was it generated a profit in its latest reporting period. The bad news is it was …

GW Pharmaceuticals (GWPH) Should Find a Place in Your Portfolio

June has been one roller coaster ride for cannabis stocks. First, the FDA reported that CBD be treated like a drug causing cannabis …

GW Pharmaceuticals (GWPH) Stock Deserves a Spot in Your Portfolio; Here’s Why

June has been one roller coaster ride for cannabis stocks. First, the FDA reported that CBD be treated like a drug causing cannabis …

GW Pharmaceuticals (GWPH) Stock Could Run Much Higher Over Time

GW Pharmaceuticals (GWPH) has recently bounced after a solid earnings report. It also announced its phase-3 trial concerning its Epidiolex oral medicine, received …

Medicinal Cannabis Stock GW Pharmaceuticals (GWPH) Could Run Much Higher Over Time

GW Pharmaceuticals (GWPH) has recently bounced after a solid earnings report. It also announced its phase-3 trial concerning its Epidiolex oral medicine, received …

Analysts Have Chosen: GWPH, APHA and CGC Are Top Cannabis Stock Picks

The cannabis market has the potential to be extremely lucrative for investors. For example, shares of cannabis grower Hexo (HEXO) are now up …

GW Pharmaceuticals (GWPH): A “Blue Chip” Cannabis Stock to Watch

By Genia Turanova For centuries, humans relied on plant-derived medicines, using — based on countless experiments and astute observation — a wide range …

GW Pharma (GWPH) Stock Could Surge on Earnings Today

GW Pharma (GWPH) has the distinction of having the first cannabis-derived prescription drug that was approved by the FDA: Epidiolex.  This drug is …

GW Pharmaceuticals (GWPH) Stock Finds a Fan in J.P Morgan

J.P Morgan analyst Cory Kasimov initiates coverage for medical cannabis company GW Pharmaceuticals (GWPH), calling it a “clear leader” in the field of cannabinoid …

Cantor Weighs in on GW Pharmaceuticals (GWPH) Stock Following DEA Rescheduling

This morning, GW Pharmaceuticals (GWPH) announced that EPIDIOLEX (cannabidiol) oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts